Selected research
Industry Research
Immunology Drug Industry Research Report 2026
Market perspective
The global Immunology Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immunology Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immunology Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immunology Drug include Eisai Co., Eli Lilly and Company, Pfizer, GlaxoSmithKline plc, Bayer AG, Seattle Genetics, Sanofi Aventis LLC., Genentech and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immunology Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immunology Drug Market by Company
Eisai Co.
Eli Lilly and Company
Pfizer
GlaxoSmithKline plc
Bayer AG
Seattle Genetics
Sanofi Aventis LLC.
Genentech
F. Hoffmann-La Roche Ltd.
Autoimmune Inc.
Active Biotech
Abbott Laboratories
Immunology Drug Segment by Type
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Immunology Drug Segment by Application
Cancer Research Centers and Institutes
Hospitals
Clinics
Immunology Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immunology Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immunology Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibodies (mAb)
- Antibody Drug Conjugates
- Immunosuppressive medication
- Others
Applications
- Cancer Research Centers and Institutes
- Hospitals
- Clinics
Companies covered
- Eisai Co.
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline plc
- Bayer AG
- Seattle Genetics
- Sanofi Aventis LLC.
- Genentech
- F. Hoffmann-La Roche Ltd.
- Autoimmune Inc.
- Active Biotech
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immunology Drug Market Size (2021-2032)
- 2.2.2 Global Immunology Drug Sales (2021-2032)
- 2.2.3 Global Immunology Drug Market Average Price (2021-2032)
- 2.3 Immunology Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Monoclonal Antibodies (mAb)
- 2.3.3 Antibody Drug Conjugates
- 2.3.4 Immunosuppressive medication
- 2.3.5 Others
- 2.4 Immunology Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Research Centers and Institutes
- 2.4.3 Hospitals
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immunology Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immunology Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Immunology Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Immunology Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Immunology Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immunology Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immunology Drug, Product Type & Application
- 3.8 Global Manufacturers of Immunology Drug, Established Date
- 3.9 Global Immunology Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai Co.
- 4.1.1 Eisai Co. Company Information
- 4.1.2 Eisai Co. Business Overview
- 4.1.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Co. Immunology Drug Product Portfolio
- 4.1.5 Eisai Co. Recent Developments
- 4.2 Eli Lilly and Company
- 4.2.1 Eli Lilly and Company Company Information
- 4.2.2 Eli Lilly and Company Business Overview
- 4.2.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly and Company Immunology Drug Product Portfolio
- 4.2.5 Eli Lilly and Company Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Immunology Drug Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline plc
- 4.4.1 GlaxoSmithKline plc Company Information
- 4.4.2 GlaxoSmithKline plc Business Overview
- 4.4.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
- 4.4.5 GlaxoSmithKline plc Recent Developments
- 4.5 Bayer AG
- 4.5.1 Bayer AG Company Information
- 4.5.2 Bayer AG Business Overview
- 4.5.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer AG Immunology Drug Product Portfolio
- 4.5.5 Bayer AG Recent Developments
- 4.6 Seattle Genetics
- 4.6.1 Seattle Genetics Company Information
- 4.6.2 Seattle Genetics Business Overview
- 4.6.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Seattle Genetics Immunology Drug Product Portfolio
- 4.6.5 Seattle Genetics Recent Developments
- 4.7 Sanofi Aventis LLC.
- 4.7.1 Sanofi Aventis LLC. Company Information
- 4.7.2 Sanofi Aventis LLC. Business Overview
- 4.7.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio
- 4.7.5 Sanofi Aventis LLC. Recent Developments
- 4.8 Genentech
- 4.8.1 Genentech Company Information
- 4.8.2 Genentech Business Overview
- 4.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Genentech Immunology Drug Product Portfolio
- 4.8.5 Genentech Recent Developments
- 4.9 F. Hoffmann-La Roche Ltd.
- 4.9.1 F. Hoffmann-La Roche Ltd. Company Information
- 4.9.2 F. Hoffmann-La Roche Ltd. Business Overview
- 4.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio
- 4.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
- 4.10 Autoimmune Inc.
- 4.10.1 Autoimmune Inc. Company Information
- 4.10.2 Autoimmune Inc. Business Overview
- 4.10.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Autoimmune Inc. Immunology Drug Product Portfolio
- 4.10.5 Autoimmune Inc. Recent Developments
- 4.11 Active Biotech
- 4.11.1 Active Biotech Company Information
- 4.11.2 Active Biotech Business Overview
- 4.11.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Active Biotech Immunology Drug Product Portfolio
- 4.11.5 Active Biotech Recent Developments
- 4.12 Abbott Laboratories
- 4.12.1 Abbott Laboratories Company Information
- 4.12.2 Abbott Laboratories Business Overview
- 4.12.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abbott Laboratories Immunology Drug Product Portfolio
- 4.12.5 Abbott Laboratories Recent Developments
5 Global Immunology Drug Market Scenario by Region
- 5.1 Global Immunology Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immunology Drug Sales by Region: 2021-2032
- 5.2.1 Global Immunology Drug Sales by Region: 2021-2026
- 5.2.2 Global Immunology Drug Sales by Region: 2027-2032
- 5.3 Global Immunology Drug Revenue by Region: 2021-2032
- 5.3.1 Global Immunology Drug Revenue by Region: 2021-2026
- 5.3.2 Global Immunology Drug Revenue by Region: 2027-2032
- 5.4 North America Immunology Drug Market Facts & Figures by Country
- 5.4.1 North America Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immunology Drug Sales by Country (2021-2032)
- 5.4.3 North America Immunology Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Immunology Drug Market Facts & Figures by Country
- 5.5.1 Europe Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immunology Drug Sales by Country (2021-2032)
- 5.5.3 Europe Immunology Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Immunology Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immunology Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immunology Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immunology Drug Market Facts & Figures by Country
- 5.7.1 South America Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immunology Drug Sales by Country (2021-2032)
- 5.7.3 South America Immunology Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Immunology Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immunology Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immunology Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Immunology Drug Sales by Type (2021-2032)
- 6.1.1 Global Immunology Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Immunology Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Immunology Drug Revenue by Type (2021-2032)
- 6.2.1 Global Immunology Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immunology Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Immunology Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immunology Drug Sales by Application (2021-2032)
- 7.1.1 Global Immunology Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Immunology Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Immunology Drug Revenue by Application (2021-2032)
- 7.2.1 Global Immunology Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immunology Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Immunology Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immunology Drug Value Chain Analysis
- 8.1.1 Immunology Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immunology Drug Production Mode & Process
- 8.2 Immunology Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immunology Drug Distributors
- 8.2.3 Immunology Drug Customers
9 Global Immunology Drug Analyzing Market Dynamics
- 9.1 Immunology Drug Industry Trends
- 9.2 Immunology Drug Industry Drivers
- 9.3 Immunology Drug Industry Opportunities and Challenges
- 9.4 Immunology Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst